Vimarsana
Biggest News Aggregation in the World

Page 23 - Beigene News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Beigene. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Beigene Today - Breaking & Trending Today

BeiGene Expands Presence in Latin America With Opening of Brazil Office - Vimarsana News

BeiGene Expands Presence in Latin America With Opening of Brazil Office

PD-1 inhibitor tislelizumab under review by Brazil’s National Health Surveillance Agency to treat non-small cell lung cancer and esophageal cancer Future regional expansion planned in... | April 13, 2023

Enlivex Therapeutics Ltd.: Enlivex, Beigene Collaborate To Test A New Combination Treatment To Fight Advanced-Stage Solid Tumors - Vimarsana News

Enlivex Therapeutics Ltd.: Enlivex, Beigene Collaborate To Test A New Combination Treatment To Fight Advanced-Stage Solid Tumors

NES-ZIONA, ISRAEL / ACCESSWIRE / April 12, 2023 / This month, Enlivex Therapeutics Ltd. (NASDAQ:ENLV) announced a new clinical collaboration agreement with Beigene Ltd to test a new combination treatment

BeiGene (NASDAQ:BGNE) Price Target Increased to $263.30 by Analysts at Bank of America - Vimarsana News

BeiGene (NASDAQ:BGNE) Price Target Increased to $263.30 by Analysts at Bank of America

BeiGene (NASDAQ:BGNE – Get Rating) had its price objective boosted by research analysts at Bank of America from $230.10 to $263.30 in a report issued on Wednesday, The Fly reports. Bank of America‘s price target would suggest a potential upside of 4.65% from the company’s current price. A number of other equities analysts have also […]

BeiGene Appoints Julius Pryor III as First Global Head of Diversity and Health Equity - Vimarsana News

BeiGene Appoints Julius Pryor III as First Global Head of Diversity and Health Equity

Pryor will spearhead BeiGene's efforts to pair global health equity with diversity and inclusion BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced the

BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint in New Jersey - Vimarsana News

BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint in New Jersey

Company Hits Construction Milestone for Flagship Manufacturing and R&D Facility in Hopewell BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, is entering a new phase